Artificial Mini Dendritic Cells Boost T Cell–Based Immunotherapy for Ovarian Cancer

Ovarian cancer is the most lethal gynecological malignancy with high recurrence rates and low survival rates, remaining a disease of high unmet need. Cancer immunotherapy, which harnesses the potential of the immune system to attack tumors, has emerged as one of the most promising treatment options...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Shanshan, Xu, Cong, Jin, Yue, Li, Yu, Zhong, Cheng, Ma, Jun, Yang, Jiani, Zhang, Nan, Li, Yuan, Wang, Chao, Yang, Zhiyou, Wang, Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Full Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141030/
https://www.ncbi.nlm.nih.gov/pubmed/32274314
http://dx.doi.org/10.1002/advs.201903301

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141030/
https://www.ncbi.nlm.nih.gov/pubmed/32274314
http://dx.doi.org/10.1002/advs.201903301

Ejemplares similares